NCT03436264

Brief Summary

The proneness to react to noxious stimuli varies widely between individuals and pain ratings of seemingly identical noxious stimuli may range from "no pain" to "excruciating pain" . Imaging studies in healthy subjects have provided useful information on the identification of the inter-individual variability in pain perception \[2,3,4\]. These studies have shown that subjective pain reports are closely related to the degree of neuronal activity in several brain regions known to be identified in pain processing. Furthermore, there has been a growing interest in understanding structural and functional mechanisms of inter-individual variability in responses to identical noxious stimuli \[5,6,7\]. Yet, the relationship between pain perception and various anatomical and functional connectivity within resting state brain networks is not completely understood. With regard to the anatomical correlate of pain sensitivity, differences in grey matter may reflect neural processes contributing to the construction and modulation of pain in healthy individuals. As such, studies are inconsistent regarding this issue, showing positive \[7\] or inverse connections \[6\] between pain sensitivity and brain morphology. The inconsistency regarding this issue warrant further investigation which may elucidate the relationship between differences in pain sensitivity and regional grey matter and may provide novel insights into brain mechanisms contributing to that topic. Understanding brain morphology and connectivity within specific regions associated with pain processing can provide reliable anchor for the individual differences in pain response. A widely used approach to examine brain morphology from MRI images is voxel based morphometry (VBM). VBM tests for statistically significant differences in regional gray matter (GM) density between study groups, and its temporal changes. Diffusion tensor imaging (DTI) is a type of diffusion weighted imaging with the advantage of being able to resolve individual functional tracts within the white matter (WM) thus, DTI parameters serve as indirect measures of structural connectivity via the degree of integrity of WM tracts.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

February 19, 2018

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

April 24, 2018

Status Verified

April 1, 2018

Enrollment Period

1.8 years

First QC Date

January 31, 2018

Last Update Submit

April 23, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • fMRI diffrences

    a. Both subgroups will demonstrate differences in gray matter density and cortical thickness in key cortical regions that are responsible for the processing and modulation of sensory stimuli, such as primary somatosensory cortex (S1), cingulate cortex (ACC/MCC/PCC), prefrontal cortex (PFC including OFC) and insula.

    2 years

Study Arms (2)

high sensitivity to pain

Other: MRI

low sensitivity to pain

Other: MRI

Interventions

MRIOTHER

fMRI

high sensitivity to painlow sensitivity to pain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of 196 healthy participants. Of these, 48 patients will undergo brain imaging

You may qualify if:

  • Healthy males and females, over the age of 18, free from chronic pain of any type.
  • No medication use (except for oral contraceptives).
  • Able to understand the purpose and instructions of the study and to sign an informed consent.

You may not qualify if:

  • Pregnant women
  • Inability to comply with study protocol.
  • A diagnosis of Raynaud's Syndrome
  • Subjects with metal implants of any kind (including pace maker) and Claustrophobia will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Health Care Campus

Haifa, 31096, Israel

RECRUITING

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Elon Eisenberg MD Professor of Neurology and Pain Medicine Head, Pain Research Unit Institute of Pain Medicine Rambam Health Care Campus

Study Record Dates

First Submitted

January 31, 2018

First Posted

February 19, 2018

Study Start

March 1, 2018

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

April 24, 2018

Record last verified: 2018-04

Locations